Dexrazoxane Dose Calculator
A precise tool for the calculation used to verify the dexrazoxane dose. This calculator is intended for healthcare professionals to ensure cardioprotective coverage during anthracycline-based chemotherapy. Do not use for clinical decisions without consulting official guidelines.
| Doxorubicin Dose (mg/m²) | Total Dexrazoxane Dose (mg) |
|---|
What is the Calculation Used to Verify the Dexrazoxane Dose?
The calculation used to verify the dexrazoxane dose is a critical safety check in oncology, designed to protect patients from the cardiotoxic effects of anthracycline chemotherapy agents like doxorubicin. Dexrazoxane (brand names Zinecard®, Totect®) is a cardioprotective agent administered before the chemotherapy drug. The standard dosing protocol relies on a fixed ratio between the dexrazoxane dose and the anthracycline dose, almost always 10:1. This means for every 1 mg/m² of doxorubicin administered, the patient should receive 10 mg/m² of dexrazoxane. The final absolute dose is then tailored to the individual by multiplying this value by their Body Surface Area (BSA).
The Dexrazoxane Dose Formula and Explanation
The core of the dexrazoxane dose calculation is straightforward. It involves two primary steps: calculating the dose relative to body size (per m²) and then determining the total patient-specific dose.
Step 1: Dexrazoxane Dose per m²
Dexrazoxane Dose (mg/m²) = Doxorubicin Dose (mg/m²) × 10
Step 2: Total Dexrazoxane Dose
Total Dexrazoxane Dose (mg) = Dexrazoxane Dose (mg/m²) × Body Surface Area (BSA, in m²)
Our calculator simplifies this by also calculating the BSA for you using the widely accepted Du Bois formula, which requires the patient’s height and weight. You can learn more about Body Surface Area calculations in our dedicated tool.
Variables Table
| Variable | Meaning | Unit (auto-inferred) | Typical Range |
|---|---|---|---|
| Doxorubicin Dose | The prescribed dose of the anthracycline drug. | mg/m² | 30 – 75 mg/m² |
| Body Surface Area (BSA) | A measurement of the total surface area of a human body. | m² | 1.5 – 2.2 m² |
| Dexrazoxane Dose | The calculated cardioprotective dose. | mg | 3000 – 15000 mg |
Practical Examples of Dexrazoxane Dose Calculation
Example 1: Standard Adult Patient
- Inputs: Doxorubicin Dose = 60 mg/m², Patient Height = 175 cm, Patient Weight = 80 kg.
- Calculation:
- First, calculate BSA (Du Bois): Approximately 1.99 m².
- Calculate Dexrazoxane Dose per m²: 60 mg/m² × 10 = 600 mg/m².
- Calculate Total Dexrazoxane Dose: 600 mg/m² × 1.99 m² = 1194 mg.
- Result: The total required dexrazoxane dose is 1194 mg.
Example 2: Patient with Renal Impairment
For patients with moderate-to-severe renal impairment (Creatinine Clearance < 40 mL/min), the dexrazoxane dose must be reduced by 50%. The ratio becomes 5:1. For a detailed analysis, see our creatinine clearance calculator.
- Inputs: Doxorubicin Dose = 50 mg/m², Patient BSA = 1.8 m², Renal Impairment = Yes.
- Calculation:
- Adjusted Ratio: 5:1.
- Calculate Dexrazoxane Dose per m²: 50 mg/m² × 5 = 250 mg/m².
- Calculate Total Dexrazoxane Dose: 250 mg/m² × 1.8 m² = 450 mg.
- Result: The total required dexrazoxane dose is 450 mg.
How to Use This Dexrazoxane Dose Calculator
- Enter Anthracycline Dose: Input the prescribed doxorubicin dose in mg/m². This is the most crucial value for the calculation used to verify the dexrazoxane dose.
- Enter Patient Height: Provide the patient’s height. Use the dropdown to select between centimeters (cm) and inches (in).
- Enter Patient Weight: Input the patient’s weight. Use the dropdown to select between kilograms (kg) and pounds (lbs).
- Review Results: The calculator instantly provides the total dexrazoxane dose in milligrams. It also shows key intermediate values like the patient’s BSA and the dexrazoxane dose per m².
- Analyze Table and Chart: Use the dynamic table and chart to visualize how the total dose changes with different anthracycline dosages for the given patient.
Key Factors That Affect Dexrazoxane Dosing
- Doxorubicin Dose: This is the primary driver of the calculation. The 10:1 ratio is standard.
- Body Surface Area (BSA): The final dose is directly proportional to the patient’s BSA. A larger BSA requires a higher total dose. Investigate our BSA formula guide for more details.
- Renal Function: As noted, creatinine clearance below 40 mL/min requires a 50% dose reduction.
- Hepatic Function: If liver impairment requires a doxorubicin dose reduction, the dexrazoxane dose should be reduced proportionally to maintain the 10:1 ratio.
- Cumulative Anthracycline Dose: Dexrazoxane is typically not initiated with the first cycle of chemotherapy. It’s recommended for patients who have already received a cumulative doxorubicin dose of 300 mg/m².
- Administration Timing: Dexrazoxane must be administered via IV infusion (typically over 15 minutes) *before* doxorubicin, with the doxorubicin infusion starting within 30 minutes of completing the dexrazoxane infusion.
Frequently Asked Questions (FAQ)
- What is the purpose of dexrazoxane?
- Dexrazoxane is a cardioprotective agent used to reduce the incidence and severity of heart muscle damage (cardiomyopathy) that can be caused by anthracycline chemotherapy drugs like doxorubicin.
- Is the 10:1 ratio always used for the dexrazoxane dose calculation?
- Yes, the 10:1 dexrazoxane-to-doxorubicin dose ratio is the FDA-approved and standard-of-care recommendation for cardioprotection. The only common exception is for patients with significant renal impairment.
- Can I use this calculator for Epirubicin?
- While a 10:1 ratio is considered reasonable for epirubicin, the optimal ratio is not as firmly established. Always consult specific institutional protocols. For more on drug interactions, see our drug interaction checker.
- What happens if a dose is missed?
- Dexrazoxane must be given before each relevant chemotherapy cycle to be effective. Missing a dose would negate its cardioprotective benefit for that specific treatment. Consult the oncology team immediately.
- Does dexrazoxane have side effects?
- Yes. Common side effects include nausea, vomiting, fatigue, and pain at the injection site. It can also cause myelosuppression, adding to the similar effects of chemotherapy itself.
- Why shouldn’t dexrazoxane be used at the start of chemotherapy?
- Studies have shown that using it from the very first cycle might slightly decrease the anti-tumor effectiveness of the chemotherapy. Therefore, it’s reserved for patients who have already reached a certain cumulative exposure to doxorubicin (300 mg/m²).
- How is Body Surface Area (BSA) calculated?
- This calculator uses the Du Bois formula: BSA (m²) = 0.007184 × Height (cm)^0.725 × Weight (kg)^0.425. This is a standard method in oncology. Check our medical calculation formulas page for more info.
- Is there a maximum dose for dexrazoxane?
- When used for extravasation (a different indication), there are maximum daily doses (e.g., 2000 mg). For cardioprotection, the dose is dictated by the 10:1 ratio and BSA, without a strict upper cap, but it’s always dependent on the planned anthracycline dose.
Related Tools and Internal Resources
To supplement your understanding and use of the calculation used to verify the dexrazoxane dose, explore these related resources:
- BSA Calculator: A detailed tool for calculating Body Surface Area using various formulas.
- Creatinine Clearance Calculator: Essential for determining if a dexrazoxane dose reduction is necessary due to renal function.
- Oncology Dosing Guide: Review institutional protocols for chemotherapy and supportive care.
- Pharmacology Database: Look up detailed drug information for anthracyclines and cardioprotective agents.